Top Stories · October 13, 2026
Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says
CadNews does not determine absolute truth or endorse political viewpoints. It compares publicly available reporting, identifies shared facts, highlights framing differences, and flags uncertainty.
About these outlets
Neutral Summary
The Federal Trade Commission (FTC) and seven states have filed a motion to hold Martin Shkreli in civil contempt for allegedly violating his lifetime ban from the pharmaceutical industry. Authorities claim Shkreli traded stocks in over 60 pharmaceutical companies and publicly promoted biotech investing via live streams on platforms like YouTube and X. The motion seeks a full accounting of his trades, divestment of holdings, and monetary fines, with potential for further incarceration if violations continue.
The Federal Trade Commission (FTC) and seven states have filed a motion to hold Martin Shkreli in civil contempt for allegedly violating his lifetime ban from the pharmaceutical industry. Authorities claim Shkreli traded stocks in over 60 pharmaceutical companies and publicly promoted biotech investing via live streams on platforms like YouTube and X. The motion seeks a full accounting of his trades, divestment of holdings, and monetary fines, with potential for further incarceration if violations continue.